ClinicalTrials.Veeva

Menu

Effects of Inspiratory Muscle Training on Stroke Rehabilitation Outcomes

H

Hong Kong Metropolitan University

Status

Enrolling

Conditions

Stroke

Treatments

Other: IMT-stable group (sitting on a stable surface)
Other: IMT-unstable group (sitting on an unstable surface)
Other: sham IMT
Other: Conventional treatment

Study type

Interventional

Funder types

Other

Identifiers

NCT06640101
No.:HE-OT2023/13

Details and patient eligibility

About

This study is designed to explore the effects of a 4-week protocol of inspiratory muscle training (IMT) at 50% maximum inspiratory pressure (MIP) on respiratory function, diaphragm thickness, balance control, exercise capacity, and quality of life in people after stroke. To ascertain the effect of IMT on the relationship between diaphragm muscle contraction and activation of other trunk muscles, this study also explores whether any effect of the 4-week IMT protocol on balance control is associated with changes in the anticipatory posture adjustments (APAs) time - the onset time of postural muscles during a required task (e.g., the rapid shoulder flexion test).

Enrollment

84 estimated patients

Sex

All

Ages

40 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 40 years and < 80 years;
  • breathing spontaneously;
  • clinically diagnosed with ischemic and/or haemorrhagic stroke;
  • duration of stroke from onset falls within 1 month to 12 months after diagnosis;
  • no thoracic or abdominal surgery within the last 6 months;
  • able to understand and follow verbal instructions;
  • no facial palsy, or mild facial palsy without limitation of labial occlusion;
  • able to maintain a resting sitting posture without feet support for at least 30 seconds;
  • no cognitive impairment (Montreal Cognitive Assessment (MoCA) score ≥ 26);
  • able to independently walk at least 10 meters with or without an assistive device.

Exclusion criteria

  • acute myocardial infarction or acute heart failure;
  • acute pain in any part of the body;
  • with respiratory illness or positive clinical signs of impaired respiratory function (such as shortness of breath, hypoxemia, chronic cough and sputum retention);
  • with chronic cardiovascular dysfunction;
  • Trunk Impairment Scale (TIS) score ≥ 20.
  • patient with a nasal feeding tube, tracheal tube and/or any condition that prevents the measurement or the implementation of the study procedure.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

84 participants in 3 patient groups

Group A (sham IMT- stable group)
Sham Comparator group
Description:
conventional treatment + sham IMT
Treatment:
Other: Conventional treatment
Other: sham IMT
Group B (IMT-stable group)
Experimental group
Description:
conventional treatment + target IMT while sitting on a stable surface
Treatment:
Other: Conventional treatment
Other: IMT-stable group (sitting on a stable surface)
Group C (IMT-unstable group)
Experimental group
Description:
conventional treatment + target IMT while sitting on an unstable surface
Treatment:
Other: Conventional treatment
Other: IMT-unstable group (sitting on an unstable surface)

Trial documents
2

Trial contacts and locations

1

Loading...

Central trial contact

William Wai-nam Tsang; Fang LIU

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems